An observational trial : patient profile of users of Secomet V®

Jansen van Rensburg, Connie E.; Gandy, Justin John; Snyman, Jacques Rene

dc.contributor.author	Jansen van Rensburg, Connie E.
dc.contributor.author	Gandy, Justin John
dc.contributor.author	Snyman, Jacques Rene
dc.date.accessioned	2011-06-13T11:48:30Z
dc.date.available	2011-06-13T11:48:30Z
dc.date.issued	2010
dc.description.abstract	Subsequent to a report published by Natasha Bolognesi in Nature Medicine in 2006 on a “herbal” product called Secomet V® researchers of the University of Pretoria undertook an observational trial to document the demographics, quality of life and disease profile of patients who purchase Secomet V®, a product that contains selenium, L-glutamin and high levels of a carbohydrate derived fulvic acid (CHD-FA). No traces of any plant extracts could be found in the product.	en_US
dc.identifier.citation	Van Rensburg, CEJ, Snyman, JR & Gandy, JJ 2010, 'An observational trial : patient profile of users of Secomet V®', South African Family Practice, vol. 52, no. 2, pp. 165. [http://www.safpj.co.za]	en_US
dc.identifier.issn	1726-426X (online)
dc.identifier.issn	1026-9177 (print)
dc.identifier.uri	http://hdl.handle.net/2263/16819
dc.language.iso	en	en_US
dc.publisher	South African Academy of Family Practice	en_US
dc.rights	© SAAFP	en_US
dc.subject	Observational trial	en_US
dc.subject	Secomet V®	en_US
dc.subject.lcsh	Pharmacology -- Research -- South Africa	en
dc.title	An observational trial : patient profile of users of Secomet V®	en_US
dc.type	Article	en_US